NEW YORK (GenomeWeb) – Singapore-based digital PCR platform manufacturer JN MedSys has been growing its business with expansion plans for China, the UK, and the US.

The firm hopes to carve out a niche in these markets for its proprietary "chip-in-a-tube" digital PCR system, which it believes combines the advantages of existing droplet- and chip-based dPCR systems in a single platform, product manager Erin Zhang said in an email.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.